Metformin vs Upadacitinib
Metformin vs Upadacitinib: Overview
This comparison examines the pharmacological differences between Metformin and Upadacitinib.
Mechanism of Action
Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.
Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.
Pharmacokinetics
Half-life: Metformin — 4-9 hours; Upadacitinib — 9-14 hours.
Chemical Properties
Molecular Formula: Metformin — C4H11N5; Upadacitinib — C17H19F3N6O.
Molecular Weight: Metformin — 129.1640 g/mol; Upadacitinib — 380.3700 g/mol.
Type: Metformin — Small molecule; Upadacitinib — Small molecule.